- Filed
- May 8, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · Mar 31, 2025 | 258.83M sh |
| Shares Outstanding | Q1 2025 · Dec 31, 2024 | 258.17M sh |
| Long Term Debt | Q1 2025 · Mar 31, 2025 | $0 |
| Long Term Debt | Q1 2025 · Dec 31, 2024 | $0 |
| Short Term Investments | Q1 2025 · Mar 31, 2025 | $48.57M |
| Short Term Investments | Q1 2025 · Dec 31, 2024 | $56.23M |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $58.09M |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $39.02M |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $59.29M |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $40.4M |
| Current Assets | Q1 2025 · Mar 31, 2025 | $139.94M |
| Current Assets | Q1 2025 · Dec 31, 2024 | $135.24M |
| Total Assets | Q1 2025 · Mar 31, 2025 | $188.27M |
| Total Assets | Q1 2025 · Dec 31, 2024 | $178.09M |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $38.01M |
| Cash And Equivalents restated | Q1 2025 · Mar 31, 2024 | $77.58M |
| Shares Diluted | Q1 2025 · Mar 31, 2024 | 250.93M sh |
| Stock Repurchased | Q1 2025 · Mar 31, 2024 | $0 |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | −$3.87M |
| Stockholders Equity | Q1 2025 · Mar 31, 2024 | −$35.76M |
| Stockholders Equity | Q1 2025 · Dec 31, 2023 | −$19.24M |
| Sga Expense restated | Q1 2025 · Mar 31, 2024 | $12.35M |
| Rd Expense | Q1 2025 · Mar 31, 2024 | $14.18M |
| Net Income | Q1 2025 · Mar 31, 2024 | −$20.67M |
| Operating Income restated | Q1 2025 · Mar 31, 2024 | −$21.22M |
| Gross Profit restated | Q1 2025 · Mar 31, 2024 | $16.04M |
| Cost Of Revenue restated | Q1 2025 · Mar 31, 2024 | $7.8M |
| Revenue restated | Q1 2025 · Mar 31, 2024 | $23.84M |